Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Maintenance Therapy in Extensive Stage Small-Cell Lung Cancer
NCT03769935Phase 2Completed
- Sponsor
- Affiliated Qingdao Central Hospital of Qingdao University
- Start
- Jan 2017
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in small cell lung cancer (SCLC), sponsored by Affiliated Qingdao Central Hospital of Qingdao University. Started Jan 2017; status: completed.
02
Drugs
tegafur
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT03769935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03769935.